GlassScriptPhysician profile
Suguru Ohira
NPI 1598281131
$10,165.91
in general payments reported to CMS, 2019-2025
12 companies · $2,640 in 2025
The $2,640 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $102 · 2020: $1,240 · 2021: $1,393 · 2023: $832 · 2024: $3,959 · 2025: $2,640.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,872 · Food and Beverage: $3,558.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,872.25 |
| Food and Beverage | $3,557.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $2,480.00 | 2020-2021 | |
| Transmedics, INC. | $2,310.27 | 2024-2025 | Organ Care System |
| W. L. Gore & Associates, INC. | $1,994.30 | 2024-2025 | Gore Tag Thoracic Endoprosthesis, Product In Development, Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Abiomed | $1,778.67 | 2021-2025 | Impella |
| Artivion, INC. | $661.61 | 2019-2025 | Cardiac Non-Synergraft, On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Amds-Ascyrus Medical |
| Edwards Lifesciences Corporation | $581.41 | 2023-2025 | |
| Kerecis Limited | $136.58 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Cook Medical LLC | $108.18 | 2025 | Icast Covered Stent System, 6mmx22mmx120cm |
| Lemaitre Vascular, INC. | $44.29 | 2025 | Restoreflow |
| Abbott Laboratories | $39.58 | 2025 | Thoratec Heartmate 3 Lvas Implant Kit, 2nd Gen Centrimag Primary Console |
| Zimmer Biomet Holdings, INC. | $31.02 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suguru Ohira listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.